Prenatal Chemicals and Genes Interplay Impacts Fetal Growth
A 2026 review by Kobayashi et al. highlights the complex interplay between prenatal chemical exposures and genetic predispositions on fetal growth. Research is expanding beyond traditional detoxification genes (CYP, GST) to include receptors, transporters, and signaling pathways. Despite study inconsistencies, a clear consensus indicates that prenatal chemical exposures are rarely innocuous, with genetic factors modulating their adverse effects. This understanding is crucial for developing personalized risk assessment and precision prevention strategies in prenatal care.
The article discusses a narrative review by Kobayashi and colleagues (2026) in Pediatric Research, emphasizing the intricate relationship between prenatal exposure to environmental and lifestyle chemicals and genetic predispositions, significantly impacting fetal growth. This research moves beyond the well-studied effects of smoking and traditional detoxification enzymes like cytochrome P450 (CYP) and glutathione S-transferase (GST). The current focus encompasses a broader range of genetic polymorphisms within receptors (e.g., aryl hydrocarbon receptor), transporters, and signal transduction pathways in both the mother and fetus, recognizing their crucial roles in mediating chemical toxicity.Despite variability and inconsistencies across studies due to diverse cohorts, exposure assessment methods, and genetic backgrounds, a consensus indicates that prenatal chemical exposures are rarely harmless. Genetic polymorphisms are shown to either exacerbate or mitigate these adverse effects on fetal development. The article highlights the importance of prospective birth cohort studies, which provide robust data through detailed biomonitoring and mother-child genotyping, helping to identify novel gene-environment interactions. Biological mechanisms frequently involve oxidative stress, inflammation, and endocrine disruption, where genetic variations can significantly alter outcomes.The public health implications are substantial, paving the way for targeted risk assessment and precision prevention strategies in prenatal care. Understanding genetic susceptibilities allows for personalized recommendations for exposure avoidance and calls for regulatory agencies to incorporate genetic factors into environmental safety standards. Emerging technologies like advanced genotyping and multi-omics approaches promise to further unravel these complex interactions. However, future research must address limitations such as small sample sizes and challenges in accurately measuring mixed chemical exposures, advocating for harmonization and inclusion of diverse populations. Ethical considerations, including genetic screening, data privacy, and socio-economic disparities, are also critical for responsible translation of these scientific insights into clinical and public health interventions.
